Molecular Basis of Food Allergy



Status:Recruiting
Conditions:Allergy, Allergy, Food Studies, Neurology, Gastrointestinal
Therapuetic Areas:Gastroenterology, Neurology, Otolaryngology, Pharmacology / Toxicology
Healthy:No
Age Range:Any - 65
Updated:1/10/2019
Start Date:January 2011
End Date:December 2030
Contact:Deirdre Burke
Email:burked2@email.chop.edu

Use our guide to learn which trials are right for you!

Molecular Basis of Food Allergy and Food Tolerance

The Study examines the molecular basis of food allergy. It explores the interaction between T
cells, InKT cells and cytokines in the development of food allergy. The study also explores
these factors in development of tolerance "outgrowing" food allergy. It will also explore the
genetic factors that lead to the development of food allergy.

The study examines all type of food allergy including IgE mediated reactions, Eosinophilic
Esophagitis and Food Protein Induced Enterocolitis

Food Allergy (FA) is a common pediatric atopic disease. Characteristically children affected
by FA become sensitized to food in the first few months of life and spontaneously outgrow the
disease by 5-6 years of age in about 80% of cases. At the present time, diagnosis of FA is
made by a combination of history, skin testing and food challenge. The pathogenic mechanisms
leading to food sensitization and subsequent spontaneous tolerance development are not
understood.

Inclusion Criteria for Study Group:

1. Males or females age 1 month to 65 years.

2. Diagnosis of Food Allergy. Food Allergy can be either IgE or non-IgE mediated food
allergy including Eosinophilic Esophagitis and Food Protein Induced Enterocolitis.

Inclusion Criteria for Control group:

1. Age and sex matched patients without food allergies

2. Sibling and parents of patients with food allergies

Inclusion Criteria for Control group with atopy:

1. Age and sex matched patients without food allergies

2. Sibling and parents of patients with food allergies

3. Patients with atopy

Exclusion Criteria

1. Underlying disease or medical problem that is judged to serious or risky to allow 3
ml/kg of blood to be drawn from a vein (such as serious anemia, cancer, poor vein
abscess, serious infections).

2. Subjects that do not meet the enrollment criteria may not be enrolled. Any violations
of these criteria will be reported in accordance with IRB policies and procedures
study procedures.
We found this trial at
1
site
South 34th Street
Philadelphia, Pennsylvania 19104
 215-590-1000
Principal Investigator: Jonathan M Spergel, MD, PhD
Children's Hospital of Philadelphia Since its start in 1855 as the nation's first hospital devoted...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials